Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study
- PMID: 35831178
- PMCID: PMC9442617
- DOI: 10.1212/WNL.0000000000200853
Nonalcoholic Fatty Liver Disease and Risk of Dementia: A Population-Based Cohort Study
Abstract
Background and objectives: Nonalcoholic fatty liver disease (NAFLD) and dementia share common risk factors including metabolic disorders. However, whether NAFLD is associated with dementia risk is unclear. We investigated the association between NAFLD and dementia risk as well as the role of cardiovascular complications including heart disease and stroke.
Methods: In this population-based matched cohort study, we identified all Swedish patients aged 65 years or older with NAFLD identified from the National Patient Register (NPR) between 1987 and 2016. These were matched with up to 10 reference individuals from the general population on age, sex, and municipality at the year of diagnosis. Incident dementia diagnosis was derived from the NPR or the Cause of Death Register until 2016. Adjusted hazard ratios (aHRs) and 95% CIs were estimated with Cox regression models.
Results: A total of 2,898 patients with NAFLD and 28,357 matched controls were identified (median age at entry, interquartile range [IQR], 70 [8]; 55.1% female). During a median follow-up of 5.5 years (IQR: 8.5 years), 145 (5.0%) patients with NAFLD and 1,291 (4.6%) reference individuals were diagnosed with dementia. Compared with the reference individuals, patients with NAFLD had higher rates of dementia (aHR 1.38, 95% CI 1.10-1.72) and vascular dementia (aHR 1.44, 95% CI 0.96-2.23, p = 0.07). Comorbid NAFLD and either heart disease (aHR 1.50 95% 1.08-2.05) or stroke (aHR 2.60 95% CI 1.95-3.47) conferred a greater risk of dementia.
Discussion: NAFLD had a modest association with increased rates of dementia. This was stronger among patients with NAFLD diagnosed with cardiovascular comorbidities.
Classification of evidence: This study provides Class II evidence that nonalcoholic fatty liver disease is associated with the development of vascular and nonvascular dementia.
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.
Figures
Similar articles
-
Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.J Hepatol. 2021 Nov;75(5):1034-1041. doi: 10.1016/j.jhep.2021.06.034. Epub 2021 Jul 3. J Hepatol. 2021. PMID: 34224779 Free PMC article.
-
Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.Gut. 2022 Sep;71(9):1867-1875. doi: 10.1136/gutjnl-2021-325724. Epub 2021 Sep 6. Gut. 2022. PMID: 34489307
-
New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk.JAMA Netw Open. 2023 Sep 5;6(9):e2335511. doi: 10.1001/jamanetworkopen.2023.35511. JAMA Netw Open. 2023. PMID: 37747732 Free PMC article.
-
Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis.Can J Gastroenterol Hepatol. 2023 Jan 25;2023:5521239. doi: 10.1155/2023/5521239. eCollection 2023. Can J Gastroenterol Hepatol. 2023. PMID: 36742347 Free PMC article. Review.
-
Depression, stroke, and dementia in patients with myocardial infarction.Dan Med J. 2018 Apr;65(4):B5423. Dan Med J. 2018. PMID: 29619929 Review.
Cited by
-
Metabolic-associated steatotic liver disease and risk of Alzheimer's disease: a real-world retrospective cohort study.Front Endocrinol (Lausanne). 2024 Sep 4;15:1451908. doi: 10.3389/fendo.2024.1451908. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39296714 Free PMC article.
-
Differences in major adverse cardiovascular events of metabolic dysfunction-associated steatotic liver disease by race and ethnicity: Letter to the editor on "Differences in liver and mortality outcomes of non-alcoholic fatty liver disease by race and ethnicity: A longitudinal real-world study".Clin Mol Hepatol. 2024 Oct;30(4):978-981. doi: 10.3350/cmh.2024.0565. Epub 2024 Aug 5. Clin Mol Hepatol. 2024. PMID: 39104001 Free PMC article. No abstract available.
-
The flavonoid fisetin reduces multiple physiological risk factors for dementia.Neurochem Int. 2024 Sep;178:105805. doi: 10.1016/j.neuint.2024.105805. Epub 2024 Jul 14. Neurochem Int. 2024. PMID: 39004102 Review.
-
Association of MAFLD and MASLD with all-cause and cause-specific dementia: a prospective cohort study.Alzheimers Res Ther. 2024 Jun 26;16(1):136. doi: 10.1186/s13195-024-01498-5. Alzheimers Res Ther. 2024. PMID: 38926784 Free PMC article.
-
Age, sex and Alzheimer's disease: a longitudinal study of 3xTg-AD mice reveals sex-specific disease trajectories and inflammatory responses mirrored in postmortem brains from Alzheimer's patients.Alzheimers Res Ther. 2024 Jun 22;16(1):134. doi: 10.1186/s13195-024-01492-x. Alzheimers Res Ther. 2024. PMID: 38909241 Free PMC article.
References
-
- Younossi Z, Tacke F, Arrese M, et al. . Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672-2682. - PubMed
-
- Joas E, Bäckman K, Gustafson D, et al. . Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension. 2012;59(4):796-801. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials